Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes

PURPOSE: Intraoperative radiotherapy (IORT) has become a viable treatment option for resectable brain metastases (BMs). As data on local control and radiation necrosis rates are maturing, we focus on meaningful secondary endpoints such as time to next treatment (TTNT), duration of postoperative cort...

Descripción completa

Detalles Bibliográficos
Autores principales: Dejonckheere, Cas S., Layer, Julian P., Hamed, Motaz, Layer, Katharina, Glasmacher, Andrea, Friker, Lea L., Potthoff, Anna-Laura, Zeyen, Thomas, Scafa, Davide, Koch, David, Garbe, Stephan, Holz, Jasmin A., Kugel, Fabian, Grimmer, Molina, Schmeel, Frederic Carsten, Gielen, Gerrit H., Forstbauer, Helmut, Vatter, Hartmut, Herrlinger, Ulrich, Giordano, Frank A., Schneider, Matthias, Schmeel, Leonard Christopher, Sarria, Gustavo R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589145/
https://www.ncbi.nlm.nih.gov/pubmed/37812290
http://dx.doi.org/10.1007/s11060-023-04464-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589145/
https://www.ncbi.nlm.nih.gov/pubmed/37812290
http://dx.doi.org/10.1007/s11060-023-04464-7

Ejemplares similares